These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21814040)

  • 1. Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.
    Julien DC; Behnke S; Wang G; Murdoch GK; Hill RA
    MAbs; 2011; 3(5):467-78. PubMed ID: 21814040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and biochemical insights on DNA structures in artificial and living systems.
    Chen N; Li J; Song H; Chao J; Huang Q; Fan C
    Acc Chem Res; 2014 Jun; 47(6):1720-30. PubMed ID: 24588263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-targeted nanoparticles for cancer therapy.
    Fay F; Scott CJ
    Immunotherapy; 2011 Mar; 3(3):381-94. PubMed ID: 21395380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
    Hong H; Yang K; Zhang Y; Engle JW; Feng L; Yang Y; Nayak TR; Goel S; Bean J; Theuer CP; Barnhart TE; Liu Z; Cai W
    ACS Nano; 2012 Mar; 6(3):2361-70. PubMed ID: 22339280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacting Pancreatic Cancer Therapy in Heterotypic
    Obaid G; Bano S; Mallidi S; Broekgaarden M; Kuriakose J; Silber Z; Bulin AL; Wang Y; Mai Z; Jin W; Simeone D; Hasan T
    Nano Lett; 2019 Nov; 19(11):7573-7587. PubMed ID: 31518145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer.
    Trail PA; King HD; Dubowchik GM
    Cancer Immunol Immunother; 2003 May; 52(5):328-37. PubMed ID: 12700948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor.
    Jacobson O; Li Q; Chen H; Niu G; Kiesewetter DO; Xu L; Cook K; Yang G; Dall'Acqua W; Tsui P; Peng L; Chen X
    J Nucl Med; 2017 Nov; 58(11):1838-1844. PubMed ID: 28546337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitizer-antibody conjugates for detection and therapy of cancer.
    van Dongen GA; Visser GW; Vrouenraets MB
    Adv Drug Deliv Rev; 2004 Jan; 56(1):31-52. PubMed ID: 14706444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.
    Bodey B
    Expert Opin Biol Ther; 2001 Jul; 1(4):603-17. PubMed ID: 11727497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in human cancer.
    Mellstedt H
    Drugs Today (Barc); 2003; 39 Suppl C():1-16. PubMed ID: 14988743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy for malignant glioma.
    Chen KS; Mitchell DA
    Adv Exp Med Biol; 2012; 746():121-41. PubMed ID: 22639164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular platforms for targeted drug delivery.
    Maso K; Grigoletto A; Vicent MJ; Pasut G
    Int Rev Cell Mol Biol; 2019; 346():1-50. PubMed ID: 31122392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and associates: Partners in targeted drug delivery.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Pharmacol Ther; 2017 Sep; 177():129-145. PubMed ID: 28315359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
    Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
    Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery.
    Li N; Zhao Q; Shu C; Ma X; Li R; Shen H; Zhong W
    Int J Pharm; 2015 Jan; 478(2):644-54. PubMed ID: 25510600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.